Biotech · Private company
Lava Therapeutics
Track this companyFree. Adds Lava Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- Interleukin 2Phase 1 · Chronic Lymphocytic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- LAVA-051Phase 1 · Chronic Lymphocytic LeukemiaClinicalTrials.gov · fetched Nov 12, 2026
- LAVA-1207Phase 1 · Metastatic Castration Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
- LAVA-1207 plus PembrolizumabPhase 1 · Metastatic Castration Resistant Prostate CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Trial of LAVA-1207 in Patients With Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate CancerPHASE1 · TERMINATED · started Jan 17, 2022ClinicalTrials.gov NCT05369000 · fetched Nov 12, 2026
- Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AMLPHASE1 · TERMINATED · started Jul 12, 2021ClinicalTrials.gov NCT04887259 · fetched Nov 12, 2026